Hospira Oxaliplatin Injection 50mg/10mL vial

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

oxaliplatin, Quantity: 5 mg/mL

Mevcut itibaren:

Hospira Australia Pty Ltd

INN (International Adı):

Oxaliplatin

Farmasötik formu:

Injection, intravenous infusion

Kompozisyon:

Excipient Ingredients: tartaric acid; sodium hydroxide; water for injections

Uygulama yolu:

Intravenous Infusion

Paketteki üniteler:

1 x 10mL pack

Sınıf:

Medicine Listed (Export Only)

Reçete türü:

(S1) This Schedule is intentionally blank

Terapötik endikasyonlar:

Oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for: * Adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. * Treatment of advanced colorectal cancer.

Ürün özeti:

Visual Identification: Clear colourless solution practically free of particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store between 20 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2013-03-26